NIV has been shown to improve daytime arterial blood gases and the symptoms associated with respiratory failure in patients with a chest wall disorder.1
- Improved gas exchange with increased PO2 and decreased PCO2
- Improved hemodynamics with decreased pulmonary artery pressure and increased right ventricular function
- Reduced work of breathing
- Normalised sleep patterns with fewer apnoeic episodes.
- Fewer hospital admissions
- Improved quality of life
- Relief from dyspnoea